GlassScriptPhysician profile
Simon A Mahler
NPI 1124051487
$51,958.41
in general payments reported to CMS, 2019-2025
11 companies · $6,459 in 2025
The $6,459 reported for 2025 was more than what 98% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,441 · 2020: $7,997 · 2021: $2,500 · 2022: $6,390 · 2023: $10K · 2024: $9,688 · 2025: $6,459.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Honoraria: $4,800 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,400 · Food and Beverage: $449 · Travel and Lodging: $294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,687.50 |
| Honoraria | $4,800.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,400.00 |
| Food and Beverage | $449.12 |
| Travel and Lodging | $294.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $15,038.03 | 2022-2024 | Stratus Cs |
| Polymedco, LLC | $10,700.00 | 2022-2025 | |
| Roche Diagnostics Corporation | $8,580.22 | 2019-2025 | |
| Abbott Laboratories | $8,443.36 | 2021-2025 | Alinity, I-Stat |
| Amgen INC. | $7,996.80 | 2020 | |
| Genetesis, INC. | $800.00 | 2021-2022 | |
| Quidel Corporation | $400.00 | 2023 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$37,310.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simon Mahler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.